Menu
GWAS Study

Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects.

Ito S, Liu X, Ishikawa Y et al.

37612283 PubMed ID
GWAS Study Type
98181 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

IS
Ito S
LX
Liu X
IY
Ishikawa Y
CD
Conti DD
ON
Otomo N
KZ
Kote-Jarai Z
SH
Suetsugu H
ER
Eeles RA
KY
Koike Y
HK
Hikino K
YS
Yoshino S
TK
Tomizuka K
HM
Horikoshi M
IK
Ito K
UY
Uchio Y
MY
Momozawa Y
KM
Kubo M
KY
Kamatani Y
MK
Matsuda K
HC
Haiman CA
IS
Ikegawa S
NH
Nakagawa H
TC
Terao C
Chapter II

Abstract

Summary of the research findings

Prostate cancer (PrCa) is the second most common cancer worldwide in males. While strongly warranted, the prediction of mortality risk due to PrCa, especially before its development, is challenging. Here, we address this issue by maximizing the statistical power of genetic data with multi-ancestry meta-analysis and focusing on binding sites of the androgen receptor (AR), which has a critical role in PrCa. Taking advantage of large Japanese samples ever, a multi-ancestry meta-analysis comprising more than 300,000 subjects in total identifies 9 unreported loci including ZFHX3, a tumor suppressor gene, and successfully narrows down the statistically finemapped variants compared to European-only studies, and these variants strongly enrich in AR binding sites. A polygenic risk scores (PRS) analysis restricting to statistically finemapped variants in AR binding sites shows among cancer-free subjects, individuals with a PRS in the top 10% have a strongly higher risk of the future death of PrCa (HR: 5.57, P = 4.2 × 10-10). Our findings demonstrate the potential utility of leveraging large-scale genetic data and advanced analytical methods in predicting the mortality of PrCa.

8,645 Japanese ancestry cases, 89,536 Japanese ancestry controls

Chapter III

Study Statistics

Key metrics and study information

98181
Total Participants
GWAS
Study Type
No
Replicated
East Asian, European, African unspecified, Hispanic or Latin American
Ancestry
Japan, Ghana, Portugal, Congo, Spain, Greece, Canada, Sweden, Netherlands, U.S., Belgium, Denmark, Poland, Uganda, Italy, U.K., France, Australia, Bulgaria, Germany
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.